0 Avaliações

ID

28290

Descrição

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party survival status

Palavras-chave

  1. 12/10/2017 12/10/2017 -
  2. 16/10/2017 16/10/2017 -
  3. 23/10/2017 23/10/2017 -
  4. 02/01/2018 02/01/2018 -
  5. 02/01/2018 02/01/2018 -
Titular dos direitos

GlaxoSmithKline

Transferido a

2 de janeiro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Third party survival status GSK study Chronic Coronary Heart Disease NCT00799903

    Third party survival status GSK study Chronic Coronary Heart Disease NCT00799903

    Assessment date
    Descrição

    Assessment date

    1. Most recent survival status assessment
    Descrição

    Most recent survival status assessment date

    Tipo de dados

    date

    Alias
    UMLS CUI [1]
    C3846084
    Survival data
    Descrição

    Survival data

    2. Subject status
    Descrição

    Subject status

    Tipo de dados

    integer

    Alias
    UMLS CUI [1]
    C2348568
    If subject known to be alive: Subject known to be alive on (date):
    Descrição

    Subject known to be alive date

    Tipo de dados

    date

    Alias
    UMLS CUI [1]
    C3274947
    If subject known to be alive: Source of information
    Descrição

    Subject alive Source of information

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C0807975
    Other source of information, specify
    Descrição

    Subject alive Other Source of information

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C0027361
    UMLS CUI [1,2]
    C0449416
    UMLS CUI [1,3]
    C1533716
    UMLS CUI [1,4]
    C0038952
    If subject died: date that site acquired death information
    Descrição

    Date that site acquired death information

    Tipo de dados

    date

    Alias
    UMLS CUI [1,1]
    C1306577
    UMLS CUI [1,2]
    C1533716
    If subject died: Source of information
    Descrição

    Subject dead Source of information

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C0683836
    UMLS CUI [1,2]
    C0011065
    Other source of information, specify
    Descrição

    Subject dead Other Source of information

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C0683836
    UMLS CUI [1,2]
    C0011065

    Similar models

    Third party survival status GSK study Chronic Coronary Heart Disease NCT00799903

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    Assessment date
    Most recent survival status assessment date
    Item
    1. Most recent survival status assessment
    date
    C3846084 (UMLS CUI [1])
    Item Group
    Survival data
    Item
    2. Subject status
    integer
    C2348568 (UMLS CUI [1])
    Code List
    2. Subject status
    CL Item
    Subject known to be alive (1)
    C2584946 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Subject died (2)
    C0011065 (UMLS CUI-1)
    (Comment:en)
    Subject known to be alive date
    Item
    If subject known to be alive: Subject known to be alive on (date):
    date
    C3274947 (UMLS CUI [1])
    Item
    If subject known to be alive: Source of information
    text
    C0807975 (UMLS CUI [1])
    Code List
    If subject known to be alive: Source of information
    CL Item
    Investigative site staff (4)
    C1512698 (UMLS CUI-1)
    C0205197 (UMLS CUI-2)
    C0281588 (UMLS CUI-3)
    (Comment:en)
    CL Item
    Health care provider other than investigative site staff (1)
    C0018724 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Family member (2)
    C0086282 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Friend or neighbor (5)
    C3842310 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Publicly available information (3)
    C1546437 (UMLS CUI-1)
    C0005957 (UMLS CUI-2)
    (Comment:en)
    CL Item
    Other (OT)
    C0205394 (UMLS CUI-1)
    (Comment:en)
    Subject alive Other Source of information
    Item
    Other source of information, specify
    text
    C0027361 (UMLS CUI [1,1])
    C0449416 (UMLS CUI [1,2])
    C1533716 (UMLS CUI [1,3])
    C0038952 (UMLS CUI [1,4])
    Date that site acquired death information
    Item
    If subject died: date that site acquired death information
    date
    C1306577 (UMLS CUI [1,1])
    C1533716 (UMLS CUI [1,2])
    Item
    If subject died: Source of information
    text
    C0683836 (UMLS CUI [1,1])
    C0011065 (UMLS CUI [1,2])
    Code List
    If subject died: Source of information
    CL Item
    Investigative site staff (4)
    (Comment:en)
    CL Item
    Health care provider other than investigative site staff (1)
    C0018724 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Family member (2)
    C0086282 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Friend or neighbor (5)
    C0079382 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Publicly available information (3)
    C1955348 (UMLS CUI-1)
    (Comment:en)
    CL Item
    Other (OT)
    (Comment:en)
    Subject dead Other Source of information
    Item
    Other source of information, specify
    text
    C0683836 (UMLS CUI [1,1])
    C0011065 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial